SuperworthSonoma Pharmaceuticals EPS SNOA
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$1.22
- Latest quarter, Q1 FY27
- −$0.09
- Fiscal year 2026
- −$1.89
Sonoma Pharmaceuticals' earnings per share was −$1.22 over the twelve months to Jun 30, 2026.
In its latest quarter, Q1 FY27, it was −$0.09.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$1.89 | n/a |
| FY2025 | −$3.04 | n/a |
| FY2024 | −$14.53 | n/a |
| FY2023 | −$31.00 | n/a |
| FY2022 | −$36.40 | n/a |
| FY2021 | −$37.80 | n/a |
| FY2020 | −$37.40 | n/a |
| FY2019 | −$274.60 | n/a |
| FY2018 | −$567.00 | −243% |
| FY2017 | $396.00 | n/a |
| FY2016 | −$554.40 | n/a |
| FY2015 | −$801.00 | −302% |
| FY2014 | $396.00 | n/a |
| FY2013 | −$1152.00 | n/a |
| FY2012 | −$1638.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | −$0.09 | n/a | −$1.22 | |
| Q4 FY26 | −$0.33 | n/a | −$1.89 | |
| Q3 FY26 | −$0.48 | n/a | −$2.04 | |
| Q2 FY26 | −$0.32 | n/a | −$2.19 | |
| Q1 FY26 | −$0.76 | n/a | −$2.46 | |
| Q4 FY25 | −$0.48 | n/a | −$3.04 | |
| Q3 FY25 | −$0.63 | n/a | −$3.95 | |
| Q2 FY25 | −$0.59 | n/a | −$4.91 | |
| Q1 FY25 | −$1.34 | n/a | −$10.07 | |
| Q4 FY24 | −$1.39 | n/a | −$14.53 | |
| Q3 FY24 | −$1.59 | n/a | −$19.34 | |
| Q2 FY24 | −$5.75 | n/a | −$30.15 |
Against its peers
Companies in Healthcare nearest Sonoma Pharmaceuticals' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SNOASonoma Pharmaceuticals | −$1.22 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Sonoma Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.